Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Formal Collaboration Agreements between the University of Oxford and the Oxford Radcliffe Hospitals NHS Trust

The University of Oxford and the Oxford Radcliffe Hospitals NHS Trust have signalled their intention to cement and strengthen their collaboration in research, teaching and patient care by agreeing terms for a formal and legally-binding relationship.

There has been a long history of joint working between the University of Oxford and the NHS hospitals in Oxford, greatly benefitting both patients and the wider community.

 

Existing collaborations include the ambitious research programmes established through the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the Oxford Radcliffe Hospitals NHS Trust (ORH) and at the Biomedical Research Unit in musculoskeletal disease at the Nuffield Orthopaedic Centre NHS Trust (NOC). These set the standard in translating science and research into new and better NHS clinical care.

The University and the Oxford Radcliffe Hospitals NHS Trust have agreed to formalise their relationship by entering into a Joint Working Agreement and a Trade Mark Licence. These will provide a formal structure and governance to the relationship between the two organisations, enhancing the ability to share ideas and activities and to function as a joint venture committed to the pursuit of excellence in patient care, research and education.

The intent is to complete these agreements at the same time as the ORH’s integration with the Nuffield Orthopaedic Centre NHS Trust, which is planned to take place later in the year (subject to approval by the Secretary of State for Health).

Professor Andrew Hamilton, Vice-Chancellor of Oxford University said: “We welcome this opportunity to strengthen our relationship with the hospitals further, forming the tight links which support the best teaching of medical students, excellence in medical research and the delivery of quality healthcare.

“The University has long worked closely with the Oxford Radcliffe Hospitals. These new agreements will recognise our strong mutual interests and will see us extend the way we work together, with benefits for the care which patients receive now and research on the treatments they may receive in the future.”

Sir Jonathan Michael, Chief Executive of the Oxford Radcliffe Hospitals NHS Trust, said: “The collaboration between the Oxford Radcliffe Hospitals and the University underpins the quality of the care that is provided to patients; to the delivery of high-quality research bringing innovation from the laboratory bench to the bedside; and the delivery of high-quality education and training of doctors. The decision by the Trust Board and the University Council to enter into these formal agreements reinforces this very important relationship.”

Similar stories

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.

New study shows overwhelming public support for donating vaccines to low-income countries

Coronavirus COVID-19 General Research

A survey led by Nuffield Department of Population Health's Health Economics Research Centre has found that most people in high-income countries support donating some of their country’s COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.